---
title: 'Patient-reported outcomes in advanced NSCLC before and during the COVID-19
  pandemic: Real-world data from the German prospective CRISP Registry (AIO-TRK-0315)'
date: '2024-02-08'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38329180/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240208170730&v=2.18.0
source: heidelberg[Affiliation]
description: Patients with lung cancer under treatment have been associated with a
  high risk of COVID-19 infection and potentially worse outcome, but real-world data
  on patient-reported outcomes (PROs) are rare. We assess patients' characteristics
  and PROs before and during the COVID-19 pandemic in an advanced non-small cell lung
  cancer (NSCLC) cohort in Germany. Patients with locally advanced or metastatic NSCLC
  from the prospective, multicentre, observational CRISP Registry (NCT02622581) were
  ...
disable_comments: true
---
Patients with lung cancer under treatment have been associated with a high risk of COVID-19 infection and potentially worse outcome, but real-world data on patient-reported outcomes (PROs) are rare. We assess patients' characteristics and PROs before and during the COVID-19 pandemic in an advanced non-small cell lung cancer (NSCLC) cohort in Germany. Patients with locally advanced or metastatic NSCLC from the prospective, multicentre, observational CRISP Registry (NCT02622581) were ...